Pfizer Asked to Pull Arthritis Drug Bextra The Food and Drug Administration has asked Pfizer to remove the anti-inflammatory drug Bextra from pharmacy shelves. The painkiller is the latest inhibitor of the enzyme known as cox-2 that has been shown to increase risks to heart, stomach and skin. The FDA named 18 other prescription and over-the-counter medicines that may pose a danger.
NPR logo

Pfizer Asked to Pull Arthritis Drug Bextra

  • Download
  • <iframe src="https://www.npr.org/player/embed/4582245/4582246" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
Pfizer Asked to Pull Arthritis Drug Bextra

Pfizer Asked to Pull Arthritis Drug Bextra

Pfizer Asked to Pull Arthritis Drug Bextra

  • Download
  • <iframe src="https://www.npr.org/player/embed/4582245/4582246" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">

The Food and Drug Administration has asked Pfizer to remove the anti-inflammatory drug Bextra from pharmacy shelves. The painkiller is the latest inhibitor of the enzyme known as cox-2 that has been shown to increase risks to heart, stomach and skin. The FDA named 18 other prescription and over-the-counter medicines that may pose a danger.